Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients
Yinghong Wang,Hamzah Abu-Sbeih,Tenglong Tang,Malek Shatila,David Faleck,Jessica Harris,Michael Dougan,Anna Olsson-Brown,Douglas B Johnson,Chanjuan Shi,Petros Grivas,Leonidas Diamantopoulos,Dwight H Owen,Clarissa Cassol,Christina A Arnold,David E Warner,Ajjai Alva,Nick Powell,Hajir Ibraheim,Enrico N De Toni,Alexander B Philipp,Jessica Philpott,Joseph Sleiman,Mark Lythgoe,Ella Daniels,Shahneen Sandhu,Alison M Weppler,Andrew Buckle,David J Pinato,Anusha Thomas,Wei Qiao,Douglas B. Johnson,Dwight H. Owen,Christina A. Arnold,David E. Warner,Enrico N. De Toni,Alexander B. Philipp,Alison M. Weppler,David J. Pinato
DOI: https://doi.org/10.1016/j.gie.2024.01.024
IF: 10.396
2024-01-01
Gastrointestinal Endoscopy
Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">No endoscopic scoring system has been established for immune-mediated colitis (IMC). This study aimed to establish such a system for IMC and explore its utility in guiding future selective immunosuppressive therapy (SIT) use compared to clinical symptoms.</AbstractText>METHODS: <AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective international 14-center study included 674 patients who developed IMC after immunotherapy and underwent endoscopic evaluation. Ten endoscopic features were selected by group consensus and assigned one point each to calculate an IMC endoscopic score (IMCES). IMCES cutoffs were chosen to maximize specificity for SIT use. This specificity was compared between IMCES, and clinical symptoms graded according to a standardized instrument.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 309 (45.8%) patients received SIT. IMCES specificity for SIT use was 82.8% with a cutoff of 4 . The inclusion of ulceration as a mandatory criterion resulted in higher specificity (85.0% for a cutoff of 4). In comparison, the specificity of a Mayo Endoscopy Score (MES) of 3 was 74.6% while specificity of clinical symptom grading was much lower at 27.4% and 12.3% respectively. Early endoscopy was associated with timely SIT use (p&lt;0.001, r=0.4084).</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the largest, multi-center study to devise an endoscopic scoring system to guide IMC management. An IMCES cutoff 4 has a higher specificity for SIT use than clinical symptoms, supporting early endoscopic evaluation for IMC.</AbstractText>
gastroenterology & hepatology